Florence Wong
9N/983
Toronto General Hospital
University of Toronto
200 Elizabeth Street
Canada
Name/email consistency: high
- Recent advances in our understanding of hepatorenal syndrome. Wong, F. Nat. Rev. Gastroenterol. Hepatol (2012)
- Management of ascites in cirrhosis. Wong, F. J. Gastroenterol. Hepatol. (2012)
- Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Wong, F., Nadim, M.K., Kellum, J.A., Salerno, F., Bellomo, R., Gerbes, A., Angeli, P., Moreau, R., Davenport, A., Jalan, R., Ronco, C., Genyk, Y., Arroyo, V. Gut (2011)
- Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment. Wong, F., Raina, N., Richardson, R. Gut (2010)
- Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis. Wong, F., Gines, P., Watson, H., Horsmans, Y., Angeli, P., Gow, P., Minini, P., Bernardi, M. J. Hepatol. (2010)
- Cirrhotic cardiomyopathy. Wong, F. Hepatol. Int (2009)
- Hepatorenal syndrome: current management. Wong, F. Curr. Gastroenterol. Rep (2008)
- Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome. Wong, F., Moore, K., Dingemanse, J., Jalan, R. Hepatology (2008)
- Drug insight: the role of albumin in the management of chronic liver disease. Wong, F. Nature Clinical Practice. Gastroenterology & Hepatology (2007)
- The use of TIPS in chronic liver disease. Wong, F. Ann. Hepatol (2006)
- Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Wong, F., Bernardi, M., Balk, R., Christman, B., Moreau, R., Garcia-Tsao, G., Patch, D., Soriano, G., Hoefs, J., Navasa, M. Gut (2005)
- Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Wong, F., Pantea, L., Sniderman, K. Hepatology (2004)
- A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Wong, F., Blei, A.T., Blendis, L.M., Thuluvath, P.J. Hepatology (2003)
- The role of liver biopsy in the management of patients with liver disease. Wong, F. Can. J. Gastroenterol. (2003)
- The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis. Wong, F., Liu, P., Blendis, L. Hepatology (2002)
- Liver and kidney diseases. Wong, F. Clin. Liver. Dis (2002)
- The cardiac response to exercise in cirrhosis. Wong, F., Girgrah, N., Graba, J., Allidina, Y., Liu, P., Blendis, L. Gut (2001)
- The pathophysiologic basis for the treatment of cirrhotic ascites. Wong, F., Blendis, L. Clin. Liver. Dis (2001)
- Sodium homeostasis with chronic sodium loading in preascitic cirrhosis. Wong, F., Liu, P., Blendis, L. Gut (2001)
- Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?. Wong, F., Siu, S., Liu, P., Blendis, L.M. Clin. Sci. (2001)
- Review: the controversy over the pathophysiology of ascites formation in cirrhosis. Wong, F., Girgrah, N., Blendis, L. J. Gastroenterol. Hepatol. (1997)
- Effects of insulin on renal function, sympathetic nervous activity and forearm blood flow in normal human subjects. Wong, F., Blendis, L., Logan, A. Clin. Invest. Med (1997)